Randomized Trialhigh evidence
Vaporized cannabis versus placebo for acute migraine: A randomized, double-blind, placebo-controlled crossover trial.
Headache·February 1, 2026·PMID 41469488
Why it mattersThis is the first randomized trial of cannabinoids for acute migraine, providing controlled evidence that a specific THC+CBD combination may offer rapid and sustained relief. It addresses a gap in clinical data on cannabis for migraine, which is relevant given patient interest and off-label use.

The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled